February 8, 2017 / 9:34 AM / 6 months ago

BRIEF-Sanofi CEO: no "Plan B" regarding anti cholesterol drug Praluent

1 Min Read

Feb 8 (Reuters) - Sanofi

* CEO says there is no "Plan B" regarding anti cholesterol drug Praluent

* Regeneron Pharmaceuticals Inc and Sanofi said in January that they would appeal the U.S. District Court ruling which banned the two companies from selling their cholesterol drug, Praluent, on grounds of patent infringement. Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below